The University of Kansas Cancer Center

https://www.kucancercenter.org/

 

Five-Year Updates on Venetoclax + Obinutuzumab for Previously Untreated CLL: Clinical Learnings From the CLL14 Study

540 views
February 1, 2023
Comments 0
Login to view comments. Click here to Login